. One of the most important advantages of cone beam CT (CBCT) is the possibility to evaluate the lesion's feeders assisting their identification and catheterization [2] . In this set, the patient's arms positioning is crucial in order not to impair CBCT imaging. Dr. Gonzalez-Aguirre et al. had elegantly demonstrated that vessels' visualization is independent from the patient's arms position, allowing to perform the entire procedure without patient's movements. This minimizes the risk of contamination and reduces procedural time.
However, literature shows that the major pivotal strength of CBCT, either mono-phasic or possibly bi-phasic, is the ability to depict in intra-procedurally ''occult lesions'', not visible at pre-procedural second-line non-invasive imaging (MRI, MDCT) [3] . This ability is not just for show, but yield to some major clinical implications: the visualization of an occult nodule identifies a subset of population experiencing fast tumour growth, having consequences on the number of adjunctive treatments controlling tumour growth (adjunctive RFA, or TACE procedures) and prioritization for transplantation [4] . Moreover, bi-phasic CBCT, with its unique ability to intra-procedural permit nodule characterization, could help in patients' reclassification and real-time TACE strategy modification [5] .
In this light would be a crucial interest for the audience to know whether the CBCT acquisition with arms down does not alter the diagnostic performance of the modality and ability of lesion's characterization, especially for those lesion localized peripherally, where the beam hardening artefacts have been shown to be significant.
Finally, patient's positioning is fundamental for CBCT imaging. By acquiring the scan with patient's arm down, liver volume would not be located within the rotation isocentre. This could be a substantial limitation for lesion located within the left liver lobe, eventually hypertrophied, and for high BMI patients.
with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
Informed Consent Statement The local institutional review board approved this study. All patients underwent full informed consent for both chemoembolization procedures and study enrolment.
